Beta-lactam-resistant penicillin (flucoxacillin, dicloxacillin, cloxacillin, nafcillin)
43 Based on limited available evidence, topical spironolactone may potentially provide an effective option for topical hormonal therapy
Warning signs include: Severe, persistent abdominal pain that may radiate to the back Nausea and vomiting that does not resolve Abdominal tenderness or distension Patients experiencing these symptoms should discontinue tirzepatide immediately and seek emergency medical evaluation
Due to the large molecule size, this ingredient is unlikely to penetrate skin
Semaglutide is approved for use in obese individuals with a body mass index (BMI) of 30 kg/m2 or higher or overweight individuals with a BMI of 27 kg/m2 or higher and at least one weight-related condition such as high blood pressure, high blood sugar, or high cholesterol
Your prescriber can help determine which compound aligns with your clinical needs and budget